These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10097404)

  • 61. Accelerator mass spectrometry for the detection of ultra-low levels of plutonium in urine, including that excreted after the ingestion of Irish sea sediments.
    Priest ND; Pich GM; Fifield LK; Cresswell RG
    Radiat Res; 1999 Dec; 152(6 Suppl):S16-8. PubMed ID: 10564928
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Double Trap Interface: A novel gas interface for high throughput analysis of biomedical samples by AMS.
    De Maria D; Fahrni SM; Lozac'h F; Marvalin C; Walles M; Camenisch G; Wacker L; Synal HA
    Drug Metab Pharmacokinet; 2021 Aug; 39():100400. PubMed ID: 34146821
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor.
    Garner RC; Goris I; Laenen AA; Vanhoutte E; Meuldermans W; Gregory S; Garner JV; Leong D; Whattam M; Calam A; Snel CA
    Drug Metab Dispos; 2002 Jul; 30(7):823-30. PubMed ID: 12065441
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Determination of amino acid isotope enrichment using liquid chromatography-mass spectrometry.
    van Eijk HM; Rooyakkers DR; Soeters PB; Deutz NE
    Anal Biochem; 1999 Jun; 271(1):8-17. PubMed ID: 10360999
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique.
    Young G; Ellis W; Ayrton J; Hussey E; Adamkiewicz B
    Xenobiotica; 2001; 31(8-9):619-32. PubMed ID: 11569529
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Accelerator MS: its role as a frontline bioanalytical technique.
    Seymour MA
    Bioanalysis; 2011 Dec; 3(24):2817-23. PubMed ID: 22185281
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.
    Garner RC
    Bioanalysis; 2010 Mar; 2(3):429-40. PubMed ID: 21083253
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA adducts: mass spectrometry methods and future prospects.
    Farmer PB; Brown K; Tompkins E; Emms VL; Jones DJ; Singh R; Phillips DH
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):293-301. PubMed ID: 15990134
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The use of accelerator mass spectrometry to obtain early human ADME/PK data.
    Lappin G; Garner RC
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):23-31. PubMed ID: 16922650
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sample preparation for quantitation of tritium by accelerator mass spectrometry.
    Chiarappa-Zucca ML; Dingley KH; Roberts ML; Velsko CA; Love AH
    Anal Chem; 2002 Dec; 74(24):6285-90. PubMed ID: 12510750
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
    Turteltaub KW; Vogel JS; Frantz CE; Fultz E
    IARC Sci Publ; 1993; (124):293-301. PubMed ID: 8225498
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An AMS method to determine analyte recovery from pharmacokinetic studies with concomitant extravascular and intravenous administration.
    Lappin G; Seymour M; Young G; Higton D; Hill HM
    Bioanalysis; 2011 Feb; 3(4):407-10. PubMed ID: 21338260
    [TBL] [Abstract][Full Text] [Related]  

  • 73. On-line measurement of intramolecular carbon isotope distribution of acetic acid by continuous-flow isotope ratio mass spectrometry.
    Yamada K; Tanaka M; Nakagawa F; Yoshida N
    Rapid Commun Mass Spectrom; 2002; 16(11):1059-64. PubMed ID: 11992508
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calorimetric low temperature detectors for low-energetic heavy ions and their application in accelerator mass spectrometry.
    Kraft-Bermuth S; Andrianov VA; Bleile A; Echler A; Egelhof P; Kiseleva A; Kiselev O; Meier HJ; Meier JP; Shrivastava A; Weber M; Golser R; Kutschera W; Priller A; Steier P; Vockenhuber C
    Rev Sci Instrum; 2009 Oct; 80(10):103304. PubMed ID: 19895057
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Accelerator mass spectrometry-enabled studies: current status and future prospects.
    Arjomand A
    Bioanalysis; 2010 Mar; 2(3):519-41. PubMed ID: 20440378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Microfabricated devices: A new sample introduction approach to mass spectrometry.
    Lazar IM; Grym J; Foret F
    Mass Spectrom Rev; 2006; 25(4):573-94. PubMed ID: 16508917
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein.
    Lappin G; Garner RC; Meyers T; Powell J; Varley P
    J Pharm Biomed Anal; 2006 Jun; 41(4):1299-302. PubMed ID: 16554138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Accelerator mass spectrometry 14C determination in CO2 produced from laser decomposition of aragonite.
    Rosenheim BE; Thorrold SR; Roberts ML
    Rapid Commun Mass Spectrom; 2008 Nov; 22(21):3443-9. PubMed ID: 18844243
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Accelerator Mass Spectrometry (AMS) in Radioecology.
    García-León M
    J Environ Radioact; 2018 Jun; 186():116-123. PubMed ID: 28882579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.